Difference between revisions of "Renal Oncocytoma"
Jump to navigation
Jump to search
| [unchecked revision] | [unchecked revision] |
| Line 38: | Line 38: | ||
=== Mutated in 2-5% === | === Mutated in 2-5% === | ||
=== mtDNA === | === mtDNA === | ||
| − | + | ||
| + | == Epigenomics (methylation) == | ||
| + | |||
| + | == Main Pathways Involved == | ||
| + | |||
| + | == Clinical Significance == | ||
| + | |||
| + | == Diagnosis == | ||
| + | |||
| + | == Prognosis == | ||
| + | |||
| + | == Theranosis == | ||
| + | |||
| + | == Familial Forms == | ||
Revision as of 20:15, 12 February 2016
Contributors
Write your comments here
Tumor Type
Write your comments here
Tumor Classification
Write your comments here
Description
Write your comments here
IHC Markers
Write your comments here
Genomic Gain/Loss/LOH
Write your comments here
Rearrangements
Write your comments here
Mutations (SNV/INDEL)
Write your comments here